Understanding how blood stem cells differ at the single-cell level
Clarifying the Origins of Blood Stem Cell Heterogeneity by Single-Cell Epigenetic State Profiling
This study is looking at how tiny differences in blood stem cells can affect their ability to grow and change into different types of blood cells, which is important for treating blood disorders and improving bone marrow transplants.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10708977 on NIH RePORTER |
What this research studies
This research investigates the differences in blood stem cells by examining their epigenetic states at a single-cell level. Using a novel microscopy-based assay called SCEPTRE, the researchers aim to identify how these differences affect the self-renewal and differentiation of hematopoietic stem cells, which are crucial for blood cell regeneration and treatment of blood disorders. The study will provide insights into the mechanisms of hematopoiesis, which is essential for developing effective therapies for conditions requiring bone marrow transplantation.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with blood disorders or those requiring bone marrow transplants.
Not a fit: Patients with non-hematological conditions or those not requiring blood cell therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for patients undergoing bone marrow transplantation and those with hematological disorders.
How similar studies have performed: Previous research has shown promising results in understanding stem cell differentiation, but this specific approach using single-cell epigenetic profiling is relatively novel.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Vaughan, Joshua — University of Washington
- Study coordinator: Vaughan, Joshua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.